Beranda › Hipertensi Paru › Oregon › Bend
Uji klinis Hipertensi Paru di Bend, OR
7 studi untuk Hipertensi Paru mencari peserta di lokasi sekitar Bend (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
- USA003, Bend
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Menerima pesertaFase 3
- Clinical Research Site, Bend
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Menerima pesertaFase 3
- Summit Health, Bend
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaStudi observasional
- Summit Health, Bend
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
- USA003, Bend
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Menerima pesertaFase 2
- Bend Memorial Clinic, Bend
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Menerima pesertaStudi observasional
- Summit Health, Bend
Uji klinis Hipertensi Paru di kota lain
- Philadelphia, PA10 studi
- Phoenix, AZ9 studi
- Aurora, CO9 studi
- Kansas City, KS8 studi
- New York City, NY8 studi
- Cincinnati, OH8 studi
- Boston, MA8 studi
- Indianapolis, IN8 studi
- Salt Lake City, UT7 studi
- Houston, TX7 studi
- Rochester, MN7 studi
- Charleston, SC7 studi
Studi lain di Bend
- Penyakit Paru Interstisial7 studi
- Kanker Prostat5 studi
- Kanker Payudara4 studi
- Kanker Kolorektal4 studi
- Melanoma3 studi
- Kanker (semua jenis)3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.